Finally, we examined α‐synuclein overexpression, a specific biomarker for parkinsonism with PINK1 defects and leading to dopaminergic loss, by quantifying mRNA abundance for its gene SNCA, as documented in several previous studies.22, 23. This evidence concerns the gene PINK1 and Parkinson disease.